Corrigendum to “PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor” [Volume 14, Issue 9, September 2021, 101152]

Detalles Bibliográficos
Autores principales: Koga, Satoko, Onishi, Hideya, Masuda, Shogo, Fujimura, Akiko, Ichimiya, Shu, Nakayama, Kazunori, Imaizumi, Akira, Nishiyama, Kenichi, Kojima, Masayuki, Miyoshi, Kei, Nakamura, Katsuya, Umebayashi, Masayo, Morisaki, Takashi, Nakamurab, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2022
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777136/
https://www.ncbi.nlm.nih.gov/pubmed/35042060
http://dx.doi.org/10.1016/j.tranon.2022.101344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777136/
https://www.ncbi.nlm.nih.gov/pubmed/35042060
http://dx.doi.org/10.1016/j.tranon.2022.101344

Ejemplares similares